Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Comparative study evaluates IR-Pilo and Vuity for presbyopia management
  • Presbyopia

Comparative study evaluates IR-Pilo and Vuity for presbyopia management

Kelsey Moroz

Pilocarpine eye drop 1.25% analogue (IR- Pilo) and Vuity eye drops are safe and effective for improving near vision in presbyopic patients, with IR-Pilo showing slightly greater benefits in accommodation and pupil constriction, according to a study.

The non-randomized comparative study included 75 participants aged 40 to 60, with one eye receiving either IR-Pilo (n = 45) or Vuity (n = 30) with the other eye served a control.

Results showed that both treatments significantly improved near vision (P < 0.001), with IR-Pilo demonstrating a stronger effect (4 vs 2.3). Both eye drops increased pupil constriction and amplitude of accommodation, though IR-Pilo had a greater impact. Distance vision remained stable, with only a minor myopic shift in the Vuity group. Intraocular pressure was unaffected, and no significant adverse effects were observed.

Reference
Mousavi SA, Rajavi Z, Sabbaghi H, et al. Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops. J Ophthalmic Vis Res. 2024;19(4):468-475. doi: 10.18502/jovr.v19i4.14578. PMID: 39917455; PMCID: PMC11795009.

Share

Related Content

  • Presbyopia

Smartphone reading habits differ between presbyopic and non-presbyopic adults

  • Presbyopia

Spotlight on TECNIS Odyssey™

  • Presbyopia

Drinking habit associated with faster progression of presbyopia in adults

  • Presbyopia

From readers to topical pharmaceuticals: a new dawn in presbyopia care

  • Presbyopia

Modeling and clinical data align on optimal pupil size for presbyopia therapy

  • Contact Lenses

Women in midlife show larger differences between preferred and full refractive correction

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon